GeneChem is a manager of focused biotechnology venture capital funds. We have over $350M in assets distributed over four funds:  GeneChem Technologies, GeneChem Therapeutics, Agechem and AmorChem. Since 1997, GeneChem has been active in investing in companies involved in drug discovery and development. Together, we have invested in over 60 companies located in the US, Canada and Europe. Today, GeneChem has established itself as a leader in the management of focused biotech funds.

At GeneChem, we believe a successful deal combines innovative science, insightful management and collaborative investor syndicate.